Filtros : "Inglaterra" "Blood" Removidos: "Bendit, Israel" "CENA-DVPROD-64" "cm" "International Conference on Network and Service Management - CNSM" Limpar

Filtros



Refine with date range


  • Source: Blood. Unidade: FM

    Subjects: SINAIS E SINTOMAS, MANIFESTAÇÕES CUTÂNEAS, QUALIDADE DE VIDA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OLSEN, Elise A. et al. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood, v. 140, n. 5, p. 419-437, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50496. Acesso em: 16 nov. 2024.
    • APA

      Olsen, E. A., Whittaker, S., Willemze, R., Pinter-brown, L., Foss, F., Geskin, L., et al. (2022). Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood, 140( 5), 419-437. doi:10.1182/blood.2021012057
    • NLM

      Olsen EA, Whittaker S, Willemze R, Pinter-brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC [Internet]. Blood. 2022 ; 140( 5): 419-437.[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50496
    • Vancouver

      Olsen EA, Whittaker S, Willemze R, Pinter-brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC [Internet]. Blood. 2022 ; 140( 5): 419-437.[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50496
  • Source: Blood. Unidade: FMRP

    Subjects: HOMEOSTASE, FAGOCITOSE, SANGUE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HERGOTT, Christopher B. et al. Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis. Blood, v. 127, n. 20, p. 2460-2471, 2016Tradução . . Disponível em: https://doi.org/10.1182/blood-2015-10-675173. Acesso em: 16 nov. 2024.
    • APA

      Hergott, C. B., Roche, A. M., Tamashiro, E., Clarke, T. B., Bailey, A. G., Laughlin, A., et al. (2016). Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis. Blood, 127( 20), 2460-2471. doi:10.1182/blood-2015-10-675173
    • NLM

      Hergott CB, Roche AM, Tamashiro E, Clarke TB, Bailey AG, Laughlin A, Bushman FD, Weiser JN. Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis [Internet]. Blood. 2016 ; 127( 20): 2460-2471.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1182/blood-2015-10-675173
    • Vancouver

      Hergott CB, Roche AM, Tamashiro E, Clarke TB, Bailey AG, Laughlin A, Bushman FD, Weiser JN. Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis [Internet]. Blood. 2016 ; 127( 20): 2460-2471.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1182/blood-2015-10-675173

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024